Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Return on Assets (2021 - 2023)

Terns Pharmaceuticals (TERN) has disclosed Return on Assets for 3 consecutive years, with 0.3% as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Return on Assets rose 5.0% year-over-year to 0.3%, compared with a TTM value of 0.3% through Sep 2023, up 5.0%, and an annual FY2022 reading of 0.26%, up 12.0% over the prior year.
  • Return on Assets was 0.3% for Q3 2023 at Terns Pharmaceuticals, down from 0.24% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.23% in Q1 2023 and bottomed at 0.36% in Q2 2022.
  • Average Return on Assets over 3 years is 0.29%, with a median of 0.29% recorded in 2021.
  • The sharpest move saw Return on Assets dropped -12bps in 2022, then grew 11bps in 2023.
  • Year by year, Return on Assets stood at 0.29% in 2021, then increased by 13bps to 0.25% in 2022, then dropped by -20bps to 0.3% in 2023.
  • Business Quant data shows Return on Assets for TERN at 0.3% in Q3 2023, 0.24% in Q2 2023, and 0.23% in Q1 2023.